Effect of Patoladi Kwatha and Phalatrikadi Kwatha in treatment of Kamala

A Comparative Clinical Study to evaluate the efficacy of Patoladi Kwatha and Phalatrikadi Kwatha in management of Bahupitta Kamala. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079536

Enrollment

Registered

2025-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age limit is from 19 to 60 years irrespective of Gender, Occupation, Religion and Economical condition. 2. Patients having raised serum bilirubin 1.5-15 mg/dl 3. Having signs and symptoms of Bahupitta Kamala with cardinal symptoms :- 1. Haridra Netra 2. Haridra Twaka 3. Rakta peeta mutrata associated symptoms:- 1. Daha 2. Dourbalya 3. Aruchi 4. Anutsaha 5. Avipaka

Exclusion criteria

Exclusion criteria: 1. Known cases of HIV infection, Malignancy 2. Patients in hepatic encephalopathy. 3. Pregnant & lactating mother 4. Psychotic patients 5. Congenital Causes -Gilbert’s Syndrome 6. Drug induced hyper bilirubinaemia.

Design outcomes

Primary

Measure	Time frame
LFTs To compare the efficacy of Patoladi Kwatha and Phalatrikadi Kwatha in Bahupitta KamalaTimepoint: Baseline 15th day,30th day,45th day	—

Secondary

Measure	Time frame
To observe adverse effects of Patoladi Kwatha and Phalatrikadi KwathaTimepoint: At base line,15th day,30th day,45th day	—

Countries

India

Contacts

Public ContactDr Vijaya Pandurang Dhumal

MAMs Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

drsachinkumarpatil@yahoo.com9822603608

Outcome results